Brokerages Set American Healthcare REIT, Inc. (NYSE:AHR) Target Price at $33.33

American Healthcare REIT, Inc. (NYSE:AHR) has earned a consensus rating of “Buy” from the seven ratings firms that are currently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have issued ratings on the stock in the last year is $33.33.

Several research analysts have recently weighed in on the company. Morgan Stanley lifted their price objective on American Healthcare REIT from $36.00 to $37.00 and gave the stock an “overweight” rating in a research report on Tuesday, March 25th. JMP Securities set a $35.00 target price on American Healthcare REIT in a report on Tuesday, March 4th. KeyCorp dropped their price target on American Healthcare REIT from $35.00 to $34.00 and set an “overweight” rating on the stock in a research note on Monday, March 31st. Citigroup reaffirmed an “outperform” rating on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $34.00 target price on shares of American Healthcare REIT in a research report on Wednesday, March 19th.

American Healthcare REIT Price Performance

Shares of NYSE AHR opened at $29.30 on Tuesday. The company has a market capitalization of $4.62 billion, a PE ratio of -61.04, a P/E/G ratio of 1.57 and a beta of 1.42. The company has a quick ratio of 0.37, a current ratio of 0.37 and a debt-to-equity ratio of 0.59. American Healthcare REIT has a twelve month low of $12.81 and a twelve month high of $31.61. The firm has a fifty day simple moving average of $29.11 and a 200 day simple moving average of $27.92.

American Healthcare REIT Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 17th. Investors of record on Monday, March 31st will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.41%. The ex-dividend date is Monday, March 31st. American Healthcare REIT’s dividend payout ratio is currently -370.37%.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its position in shares of American Healthcare REIT by 94.8% during the fourth quarter. Vanguard Group Inc. now owns 15,357,331 shares of the company’s stock worth $436,455,000 after acquiring an additional 7,474,374 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in shares of American Healthcare REIT by 29.0% in the fourth quarter. Principal Financial Group Inc. now owns 12,238,887 shares of the company’s stock valued at $347,831,000 after purchasing an additional 2,750,137 shares in the last quarter. Deutsche Bank AG lifted its holdings in shares of American Healthcare REIT by 2.3% in the fourth quarter. Deutsche Bank AG now owns 4,310,788 shares of the company’s stock valued at $122,513,000 after purchasing an additional 94,925 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of American Healthcare REIT by 46.4% during the fourth quarter. Geode Capital Management LLC now owns 3,699,793 shares of the company’s stock valued at $105,171,000 after buying an additional 1,172,670 shares during the last quarter. Finally, State Street Corp grew its holdings in American Healthcare REIT by 221.6% during the third quarter. State Street Corp now owns 3,683,691 shares of the company’s stock worth $96,473,000 after buying an additional 2,538,177 shares in the last quarter. Institutional investors and hedge funds own 16.68% of the company’s stock.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.